Abstract
Newcastle disease virus (NDV), also known as avian paramyxovirus 1, causes a devastating disease globally in over 250 species of birds known as Newcastle disease. All the viruses belong to a single serotype but categorized into eighteen genotypes based on sequence analysis of the fusion gene. The virus is continuously evolving leading to generation of new genotypes. The clinical manifestation of the disease varies depending on the pathotype of the virus. Very virulent viruses cause severe mortality in susceptible birds whereas less virulent ones cause mild or inapparent symptoms. Diagnosis of the disease is carried out by conventional and molecular tests. The virus can be controlled by live as well as killed vaccines prepared out of less or moderately virulent viruses with considerable level of protection. Recently, genotype-matched vaccines are prepared by reverse genetics for disease control. The virus has a potential to be used as a vector for delivery of foreign immunogenic genes of poultry and other livestock as live-vectored vaccines. Considerable improvements have been made in using the virus as a potential anti-cancer therapeutic for ameliorating cancers of animals and humans. The present chapter delves the various epidemiological dynamics of the virus, diagnosis strategies, and control measures.
Keywords
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Abolnik C, Horner RF, Bisschop SP et al (2004) A phylogenetic study of South African Newcastle disease virus strains isolated between 1990 and 2002 suggests epidemiological origins in the Far East. Arch Virol 149:603–619
Aldous EW, Mynn JK, Banks J et al (2003) A molecular epidemiological study of avian paramyxovirus type 1 (Newcastle disease virus) isolates by phylogenetic analysis of a partial nucleotide sequence of the fusion protein gene. Avian Pathol 32:239–225
Alexander DJ (1998) Newcastle disease and other avian paramyxoviruses, vol 1988. Newcastle Disease, Kluwer Academic Publishers, Boston, pp 11–22
Alexander DJ (2001) Gordon memorial lecture Newcastle disease. Br Poult Sci 42:5–22
Alexander DJ (2003) Newcastle disease, other avian paramyxoviruses, and pneumovirus infection. In: Disease of poultry, ed. Shaif YM, Barnes HJ, Glisson JR, et al 12 pp. 75–100. Blackwell Oxford
Alexander DJ, Campbell G, Manvell RJ et al (1992) Characterisation of an antigenically unusual virus responsible for two outbreaks of Newcastle disease in the Republic of Ireland in 1990. Vet Rec 130:65–68
Alexander DJ, Manvell RJ, Lowings JP et al (1997) Antigenic diversity and similarities detected in avian paramyxovirus type 1 (Newcastle disease virus) isolates using monoclonal antibodies. Avian Pathol 26:399–418
Antal M, Farkas T, Germán P et al (2007) Real-time reverse transcription-polymerase chain reaction detection of Newcastle disease virus using light upon extension fluorogenic primers. J Vet Diagn Investig 19(4):400–404
Ballagi-Pordány A, Wehmann E, Herczeg J et al (1996) Identification and grouping of Newcastle disease virus strains by restriction site analysis of a region from the F gene. Arch Virol 141:243–261
Basavarajappa KM, Kumar S, Khattar SK et al (2014) A recombinant Newcastle disease virus (NDV) expressing infectious laryngotracheitis virus (ILTV) surface glycoprotein D protects against highly virulent ILTV and NDV challenges in chickens. Vaccine 32:3555–3563
Beard CW, Wilkes WJ (1985) A comparison of Newcastle disease hemagglutination-inhibition test results from diagnostic laboratories in the southeastern United States. Avian Dis 29(4):1048–1056
Berinstein A, Vazquez-Rovere C, Asurmendi S et al (2005) Mucosal and systemic immunization elicited by Newcastle disease virus transgenic plants as antigens. Vaccine 23:5583–5589
Bhuvaneswari S, Tirumurugaan KG, Jones JC et al (2014) Complete genome sequence of a Newcastle disease virus from a Coturnix coturnix japonica (Japanese Quail) covey in India. Genome Announc 2(3):e00374–e00314
Bogoyavlenskiy A, Berezin V, Prilipov A et al (2009) Newcastle disease outbreaks in Kazakhstan and Kyrgyzstan during 1998, 2000, 2001, 2003, 2004, and 2005 were caused by viruses of the genotypes VIIb and VIId. Virus Genes 39:94–101
Boursnell ME, Green PF, Samson AC et al (1990) A recombinant fowlpox virus expressing the hemagglutinin-neuraminidase gene of Newcastle disease virus protects chickens against challenge by NDV. Virology 178:297–300
Brown CC, King DJ, Seal BS (1999) Pathogenesis of Newcastle disease in chickens experimentally infected with viruses of different virulence. Vet Pathol 36:125–132
Cadman HF, Kelly PJ, de Angelis ND et al (1997) Comparison of enzyme-linked immunosorbent assay and haemagglutination inhibition test for the detection of antibodies against Newcastle disease virus in ostriches (Struthiocamelus). Avian Pathol 26(2):357–363
Cattoli G, Fusaro A, Monne I et al (2010) Emergence of a new genetic lineage of Newcastle disease virus in West and Central Africa—implications for diagnosis and control. Vet Microbiol 142(3–4):168–176
Chang PW (1981) Viral Zoonosis Vol II CRC Press Boca Raton pp: 261–274
Chellappa MM, Dey S, Gaikwad S et al (2017) Rescue of a recombinant Newcastle disease virus strain R2B expressing green fluorescent protein. Virus Genes 53:410–417
Collins MS, Bashiruddin JB, Alexander DJ (1993) Deduced amino acid sequences at the fusion protein cleavage site of Newcastle disease virus showing variation in antigenicity and pathogenicity. Arch Virol128:363–370
Collins PL, Whitehead SS, Bukreyev A et al (1999) Rational design of live-attenuated recombinant vaccine virus for human respiratory syncytial virus by reverse genetics. Adv Virus Res 54:423–451
Courtney SC, Susta L, Gomez D et al (2013) Highly divergent virulent isolates of Newcastle disease virus from the Dominican Republic are members of a new genotype that may have evolved unnoticed for over 2 decades. J Clin Microbiol 51(2):508–517
Crawford M (1930) Ranikhet Ann. Rept. Govt. Vet. Surg. Colombo
Curran J (1996) Reexamination of the Sendai Virus P Protein Domains Required for RNA Synthesis: A Possible Supplemental Role for the P Protein. Virology 221(1):130–140
Cvelic-Cabrilo V, Mazija H, Bidin Z et al (1992) Correlation of haemagglutination inhibition and enzyme-linked immunosorbent assays for antibodies to Newcastle disease virus. Avian Pathol 21(3):509–512
Czegledi A, Ujvari D, Somogyi E et al (2006) Third genome size category of avian paramyxovirus serotype 1 (Newcastle disease virus) and evolutionary implications. Virus Res 120:36–48
Czifra G, Nilsson M, Alexander DJ et al (1996) Detection of PMV-1 specific antibodies with a monoclonal antibody blocking enzyme-linked immunosorbent assay. Avian Pathol 25(4):691–703
Dai C, Kang H, Yang W et al (2015) O-2′-hydroxypropyltrimethyl ammonium chloride chitosan nanoparticles for the delivery of live Newcastle disease vaccine. Carbohydr Polym 130:280–289
Das M, Kumar S (2015) Recombinant phosphoprotein based single serum dilution ELISA for rapid serological detection of Newcastle disease virus. J Virol Methods 225:64–69
de Almeida RS, Hammoumi S, Gil P et al (2013) New avian paramyxoviruses type I strains identified in Africa provide new outcomes for phylogeny reconstruction and genotype classification. PLoS One 8(10):e76413
Dey S, Chellappa MM, Gaikwad S et al (2014) Genotype characterization of commonly used Newcastle disease virus vaccine strains of India. PLoS One 9(6):e98869
Dey S, Chellappa MM, Pathak DC et al (2017) Newcastle disease virus vectored bivalent vaccine against virulent infectious bursal disease and Newcastle disease of chickens. Vaccines 5:31. https://doi.org/10.3390/vaccines5040031
Diel DG, da Silva LH, Liu H et al (2012) Genetic diversity of avian paramyxovirus type 1: proposal for a unified nomenclature and classification system of Newcastle disease virus genotypes. Infect Genet Evol 12(8):1770–1779
Dimitrov KM, Ramey AM, Qiu X et al (2016) Temporal, geographic, and host distribution of avian paramyxovirus 1 (Newcastle disease virus). Infect Genet Evol 39:22–34
DiNapoli JM, Kotelkin A, Yang L et al (2007) Newcastle disease virus, a host range restricted virus, as a vaccine vector for intra nasal immunization against emerging pathogens. Proc Natl Acad Sci U S A 104:9788–9793
Doyle TM (1927) A hitherto unrecorded disease of fowls due to a filter passing virus. J Comp Pathol 40:144–169
Edwards JJ (1928) A new fowl disease. Ann Rep Inst Vet Sci Muktheswar:14–18
Errington W, Steward M, Emmerson PT (1995) A diagnostic immunoassay for Newcastle disease virus based on the nucleocapsid protein expressed by a recombinant baculovirus. J Virol Methods 55:357–365
Farkas T, Antal M, Sámi L et al (2007) Rapid and simultaneous detection of avian influenza and Newcastle disease viruses by duplex polymerase chain reaction assay. Zoonoses Public Health 54(1):38–43
Ge J, Deng G, Wen Z et al (2007) Newcastle disease virus based live attenuated vaccine completely protects chickens and mice from lethal challenge of homologous and heterologous H5N1 avian influenza viruses. J Virol 81:150–158
Gogoi P, Ganar K, Kumar S (2015) Avian paramyxovirus: a brief review. Transbound Emerg Dis 64:53–67
Gohm DS, Thur B, Hofmann MA (2000) Detection of Newcastle disease virus in organs and faeces of experimentally infected chickens using RT-PCR. Avian Pathol 29:143–152
Gopinath VP, Raj GD, Raja A et al (2011) Rapid detection of Newcastle disease virus replication in embryonated chicken eggs using quantitative real time polymerase chain reaction. J Virol Methods 171:98–101
Homhuan A, Prakongpan S, Poomvises P et al (2004) Virosome and ISCOM vaccines against Newcastle disease: preparation, characterization and immunogenicity. Eur J Pharm Sci 22:459–468
Hooper PT, Hansson E, Young JG et al (1999) Lesions in the upper respiratory tract in chickens experimentally infected with Newcastle disease viruses isolated in Australia. Aust Vet J 77:50–51
Hu H, Roth JP, Estevez CN et al (2011) Generation and evaluation of a recombinant Newcastle disease virus expressing the glycoprotein (G) of avian metapneumovirus subgroup C as a bivalent vaccine in turkeys. Vaccine 29:8624–8633
Huang Z, Elankumaran S, Yunus AS et al (2004) A recombinant Newcastle disease virus expressing VP2 protein of infectious bursal disease virus protects against NDV and IBDV. J Virol 78:10054–10063
Jakhesara SJ, Prasad VV, Pal JK et al (2016) Pathotypic and sequence characterization of Newcastle disease viruses from vaccinated chickens reveals circulation of genotype II, IV and XIII and in India. Transbound Emerg Dis 63:523–539
Jestin V, Jestin A (1991) Detection of Newcastle disease virus RNA in infected allantoic fluids by in vitro enzymatic amplification (PCR). Arch Virol 118:151–161
Jestin V, Cherbonnel M, L’Hospitalier R, Bennejean G (1989) An ELISA blocking test using a peroxidase-labelled anti-HN monoclonal antibody for the specific titration of antibodies to avian paramyxovirus type 1 (PMV1). Arch Virol 105(3–4):199–208
Kang Y, Xiang B, Yuan R et al (2016) Phylogenetic and pathotypic characterization of Newcastle disease viruses circulating in South China and transmission in different birds. Front Microbiol 7:119
Khulape SA, Gaikwad SS, Chellappa MM et al (2014) Complete genome sequence of a Newcastle disease virus isolated from wild peacock (Pavocristatus) in India. Genome Announc 2(3).: pii: e00495–14
Kim LM, King DJ, Curry PE et al (2007a) Phylogenetic diversity among low virulence Newcastle disease viruses from waterfowl and shorebirds and comparison of genotype distributions to poultry-origin isolates. J Virol 81:12641–12653
Kim LM, King DJ, Suarez DL et al (2007b) Characterization of class I Newcastle disease virus isolates from Hong Kong live bird markets and detection using real-time reverse transcription-PCR. J Clin Microbiol 45:1310–1314
Kommers GD, King DJ, Seal BS et al (2003a) Pathogenesis of chicken-passaged Newcastle disease viruses isolated from chickens and wild and exotic birds. Avian Dis 47:319–329
Kommers GD, King DJ, Seal BS et al (2003b) Virulence of six heterogenous-origin Newcastle disease virus isolates before and after sequential passage indomestic chickens. Avian Pathol 32:81–93
Koppad S, Raj GD, Gopinath VP et al (2010) Calcium phosphate coupled Newcastle disease vaccine elicits humoral and cell mediated immune responses in chickens. Res Vet Sci 91:384–390
Kou YT, Chueh LL, Wang CH (1999) Restriction fragment length polymorphism analysis of the F gene of Newcastle disease viruses isolated from chickens and an owl in Taiwan. J Vet Med Sci 61:1191–1195
Kraneveld FC (1926) Ned-Ind. Bl. Diergenesk. 38:448–451. Cited by Alexander, D.J. 1988. In: Newcastle disease. Kluwer Academic Publications, Boston
Krishnamurthy S, Huang Z, Samal SK (2000) Recovery of a virulent strain of Newcastle disease virus from cloned cDNA: expression of a foreign gene results in growth retardation and attenuation. Virology 278:168–182
Lamb RA, Parks GD (2007) Paramyxoviridae: the viruses and their replication. In: Knipe DM, Howley PM, Griffin DE, Lamb RA, Martin MA, Roizman B, Philadelphia SSE (eds) Fields Virology, 5th edn. Lippincott Williams &Wilkins, Philadelphia, pp 1449–1496
Lee TC, Yusoff K, Nathan S et al (2006) Detection of virulent Newcastle disease virus using a phage-capturing dot blot assay. J Virol Methods 136(1–2):224–229
Liu H, Zhao Y, Zheng D, Lv Y et al (2011) Multiplex RT-PCR for rapid detection and differentiation of class I and class II Newcastle disease viruses. J Virol Methods 171(1):149–155
Liu T, Song Y, Yang Y et al (2019) Hemagglutinin–neuraminidase and fusion genes are determinants of NDV thermostability. Vet Microbiol 228:53–60
Lockaby SB, Hoerr FJ, Ellis AC et al (1993) Immunohistochemical detection of Newcastle disease virus in chickens. Avian Dis 37:433–437
Loke CF, Omar AR, Raha AR et al (2005) Improved protection from velogenic Newcastle disease virus challenge following multiple immunizations with plasmid DNA encoding for F and HN genes. Vet Immunol Immunopathol 106(3–4):259–267
Ma Q, Yu W, Su X (2010) Detection of Newcastle disease virus with quantum dots-resonance light scattering system. Talanta 82(1):51–55
Makkay AM, Krell PJ, Nagy E (1999) Antibody detection-based differential ELISA for NDV infected or vaccinated chicken versus DNV HN-subunit vaccinated chickens. Vet Microbiol 66:209–222
Mase M, Imai K, Sanada Y et al (2002) Phylogenetic analysis of Newcastle disease virus genotypes isolated in Japan. J Clin Microbiol 40:3826–3830
McGinnes LW, Homer P, Laliberete JP et al (2010) Assembly and biological and immunological properties of Newcastle disease virus-like particles. J Virol 84:4513–4523
Meulemans G, Letelhier G, Gonze M et al (1988) Newcastle disease virus F glycoprotein expressed from a recombinant vaccines virus vector protects chickens against live virus challenge. Avian Pathol 17:821–827
Miers LA, Bankowski RA, Zee YC (1983) Optimizing the enzyme linked immunosorbent assay for evaluating the immunity of chickens to Newcastle disease. Avian Dis 27:1112–1125
Miller PJ, Decanini EL, Afonso CL (2010) Newcastle disease: evolution of genotypes and related diagnostic challenges. Infect Genet Evol 10(1):26–35
Mohan CM, Dey S, Kumanan K (2006a) Restriction enzyme analysis of tissue culture adapted velogenic Newcastle disease virus. Vet Res Commun 30:455–466
Mohan CM, Dey S, Rai A et al (2006b) Recombinant haemagglutinin neuraminidase antigen based single serum dilution ELISA for rapid serological profiling of Newcastle disease virus. J Virol Methods 138:117–122
Mohan CM, Dey S, Kumanan K et al (2007) Adaptation of a velogenic Newcastle disease virus to Vero cells: assessing the molecular changes before and after adaptation. Vet Res Commun 31:371–383
Morgan RW, Gelb J, Pope CR et al (1993) Efficacy in chickens of a herpesvirus of Turkey recombinant vaccine containing the fusion gene of Newcastle disease virus: onset of protection and effect of maternal antibodies. Avian Dis 37(4):1032–1040
Nakamura K, Ueda H, Tanimura T et al (1994) Effect of mixed live vaccine (Newcastle disease and infectious bronchitis) and Mycoplasma gallisepticum on the chicken respiratory tract and on Escherichia coli infection. J Comp Pathol 111:33–42
Nakaya T, Cros J, Park MS et al (2001) Recombinant Newcastle disease virus as a vaccine vector. J Virol 75:11868–11873
Nanthakumar T, Kataria RS, Tiwari AK et al (2000a) Pathotyping of Newcastle disease viruses by RT-PCR and restriction enzyme analysis. Vet Res Commun 24:275–286
Nanthakumar T, Tiwari AK, Kataria RS et al (2000b) Sequence analysis of the cleavage site-encoding region of the fusion protein gene of Newcastle disease viruses from India and Nepal. Avian Pathol 29(6):603–607
Nath B, Barman N, Kumar S (2016) Molecular characterization of Newcastle disease virus strains isolated from different outbreaks in Northeast India during 2014–15. Microb Pathog 91:85–91
Nelson NJ (1999) Scientific interest in Newcastle disease virus is reviving. J Natl Cancer Inst 91:1708–1710
Nidzworski D, Rabalski L, Gromadzka B (2011) Detection and differentiation of virulent and avirulent strains of Newcastle disease virus by real-time PCR. J Virol Methods 173(1):144–149
Ochi Y, Hashimoto K (1929) Uber eineneueGeflugelseuche in Korea. 6th Rept, Govt Inst. Vet Res 16
Park MS, Steel J, Garcia-Sastre A et al (2006) Engineered viral vaccine constructs with dual specificity: avian influenza and Newcastle disease. Proc Natl Acad Sci U S A 103:8203–8208
Peeters BP, de Leeuw OS, Koch G et al (1999) Rescue of Newcastle disease virus from cloned cDNA: evidence that cleavability of the fusion protein is a major determinant for virulence. J Virol 73:5001–5009
Perozo F, Merino R, Afonso CL et al (2008) Biological and phylogenetic characterization of virulent Newcastle disease virus circulating in Mexico. Avian Dis 52:472–479
Pham HM, Nakajima C, Ohashi K et al (2005) Loop-mediated isothermal amplification for rapid detection of Newcastle disease virus. J Clin Microbiol 43(4):1646–1650
Rauw F, Gardin Y, Palya V et al (2010) The positive adjuvant effect of chitosan on antigen-specific cell-mediated immunity after chicken vaccination with live Newcastle disease vaccine. Vet Immunol Immunopathol 134(3–4):249–258
Reagan RL, Lillie MG (1947) Transmission of the virus of Newcastle disease to Syrian hamster. Am J Vet Res 8:136–138
Reichard KW, Lorence RM, Cascino CJ et al (1992) Newcastle disease virus selectively kills human tumor cells. J Surg Res 52:448–453
Rodier E (1928) Philippines fowl disease. Proc Soc Exptl Biol Med 25:781–783
Romer-Oberdorfer A, Mundt E, Mebatsion T et al (1999) Generation of recombinant lentogenic Newcastle disease virus from cDNA. J Gen Virol 80:2987–2995
Russell PH, Alexander DJ (1983) Antigenic variation of Newcastle disease virus strains detected by monoclonal antibodies. Arch Virol 75:243–253
Schelling E, Thur B, Griot C et al (1999) Epidemiological study of Newcastle disease in backyard poultry and wild bird populations in Switzerland. Avian Pathol 28(3):263–272
Shirvani E, Paldurai A, Manoharan VK et al (2018) A recombinant Newcastle disease virus (NDV) expressing S protein of infectious bronchitis virus (IBV) protects chickens against IBV and NDV. Sci Rep 8(1):11951
Snoeck CJ, Ducatez MF, Owoade AA et al (2009) Newcastle disease virus in West Africa: new virulent strains identified in non-commercial farms. Arch Virol 154:47–54
Steel J, Burmakina SV, Thomas C et al (2008) A combination in-ovo vaccine for avian influenza virus and Newcastle disease virus. Vaccine 26(4):522–531
Subbiah M, Yan Y, Rockemann D et al (2008) Experimental infection of calves with Newcastle disease virus induces systemic and mucosal antibody responses. Arch Virol 153:1197–1200
Takimoto T, Portner A (2004) Molecular mechanism of paramyxovirus budding. Virus Res 106:133–145
Taylor J, Edbauer C, Rey-Senelonge A et al (1990) Newcastle disease virus fusion protein expressed in a fowlpox virus recombinant confers protection in chickens. J Virol 64(4):1441–1450
Terregino C, Capua I (2009) Conventional diagnosis of Newcastle disease virus infection. In: Capua I, Alexander DJ (eds) Avian influenza and Newcastle disease. Springer, Milan, pp 123–125
Tirumurugaan KG, Vinupriya MK, Vijayarani K et al (2011) Analysis of the fusion protein cleavage site of Newcastle disease virus isolates from India reveals preliminary evidence for the existence of II, VI and VII genotypes. Indian J Virol 22(2):131–137
Toro H, Zhao W, Breedlove C et al (2014) Infectious bronchitis virus S2 expressed from recombinant virus confers broad protection against challenge. Avian Dis 53:83–89
Tsai HJ, Chang KH, Tseng CH et al (2004) Antigenic and genotypical characterization of Newcastle disease viruses isolated in Taiwan between 1969 and 1996. Vet Microbiol 104:19–30
Wang Z, Liu H, Xu J et al (2006) Genotyping of Newcastle disease viruses isolated from 2002 to 2004 in China. Ann N Y Acad Sci 1081:228–239
Wang XJ, Li CG, Chi XJ et al (2011) Characterisation and evaluation of antiviral recombinant peptides based on the heptad repeat regions of NDV and IBV fusion glycoproteins. Virology 416(1–2):65–74
Wehmann E, Herczeg J, BallagiPordany A et al (1997) Rapid identification of Newcastle disease virus vaccine strain LaSota and B1 by restriction site analysis of their matrix gene. Vaccine 15:1430–1433
Wilson RA, Perrotta C Jr, Frey B et al (1984) An enzyme-linked immunosorbent assay that measures protective antibody levels to Newcastle disease virus in chickens. Avian Dis 28(4):1079–1085
Wise MG, Sellers HS, Alvarez R et al (2004) RNA-dependent RNA polymerase gene analysis of worldwide Newcastle disease virus isolates representing different virulence types and their phylogenetic relationship with other members of the paramyxoviridae. Virus Res 104:71–80
World Organization for Animal Health (OIE): 2008, Chapter 2.3.14 In: Manual of diagnostic tests and vaccines for terrestrial animals, 6th 576–589 OIE Paris
Yadav K, Pathak DC, Saikia DP et al (2018) Generation and evaluation of a recombinant Newcastle disease virus strain R2B with an altered fusion protein cleavage site as a vaccine candidate. Microb Pathog 118:230–237
Yu L, Wang Z, Jiang Y et al (2001) Characterization of newly emerging Newcastle disease virus isolates from the People’s republic of China and Taiwan. J Clin Microbiol 39:3512–3519
Zhang L, Zhang M, Li J et al (2008) Enhancement of mucosal immune responses by intranasal co-delivery of Newcastle disease vaccine plus CpG oligonucleotide in SPF chickens in vivo. Res Vet Sci 85(3):495–502
Zhao W, Spatz S, Zhang Z et al (2014) Newcastle disease virus (NDV) recombinants expressing infectious laryngotracheitis virus (ILTV) glycoproteins gB and gD protect chickens against ILTV and NDV challenges. J Virol 88:8397–8406
Zhao K, Rong G, Hao Y et al (2016a) IgA response and protection following nasal vaccination of chickens with Newcastle disease virus DNA vaccine nanoencapsulated with Ag@SiO2 hollow nanoparticles. Sci Rep 6:25720
Zhao K, Sun Y, Chen G et al (2016b) Biological evaluation of N-2-hydroxypropyl trimethyl ammonium chloride chitosan as a carrier for the delivery of live Newcastle disease vaccine. Carbohydr Polym 149:28–39
Zhao P, Sun L, Sun X et al (2017) Newcastle disease virus from domestic mink, China, 2014. Vet Microbiol 198:104–107
Zhao Y, Liu H, Cong F et al (2018) Phosphoprotein contributes to the thermostability of Newcastle disease virus. Biomed Res Int 2018:8917476
Acknowledgments
All the authors of the manuscript thank and acknowledge the institute.
Conflict of Interest
There is no conflict of interest.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Dey, S. et al. (2019). Newcastle Disease Virus. In: Malik, Y., Singh, R., Yadav, M. (eds) Recent Advances in Animal Virology. Springer, Singapore. https://doi.org/10.1007/978-981-13-9073-9_17
Download citation
DOI: https://doi.org/10.1007/978-981-13-9073-9_17
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-13-9072-2
Online ISBN: 978-981-13-9073-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)